Showing results (71-80 of 91) with videos related to
Sort By:
Pageof 10
The New England Journal of Medicine|September 11, 2009
Asymptomatic reactivation of JC virus in patients treated with natalizumabYiping Chen, Evelyn Bord, Troy Tompkins, et al.Menopause (New York, N.Y.)|October 2, 2013
Association between the vaginal microbiota, menopause status, and signs of vulvovaginal atrophyRebecca M Brotman, Michelle D Shardell, Pawel Gajer, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 10, 2005
B lymphocyte activation by human papillomavirus-like particles directly induces Ig class switch recombination via TLR4-MyD88Rongcun Yang, Francisco Martinez Murillo, Michael J Delannoy, et al.European Journal of Immunology|April 14, 2022
Anti-IFN-α/-ω neutralizing antibodies from COVID-19 patients correlate with downregulation of IFN response and laboratory biomarkers of disease severityFederica Frasca, Mirko Scordio, Letizia Santinelli, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 20, 2011
JC virus antibody and viremia as predictors of progressive multifocal leukoencephalopathy in human immunodeficiency virus-1-infected individualsRaphael P Viscidi, Nina Khanna, Chen S Tan, et al.International Journal of Cancer|February 14, 2003
Lack of serological evidence for an association between simian virus 40 and lymphomaSilvia de Sanjose, Keerti V Shah, Eva Domingo-Domenech, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 10, 2010
Human papillomavirus types 16, 18, and 31 serostatus and prostate cancer risk in the Prostate Cancer Prevention TrialSiobhan Sutcliffe, Raphael P Viscidi, Cathee Till, et al.Medical Microbiology and Immunology|November 11, 2024
MPXV infection impairs IFN response but is partially sensitive to IFN-γ antiviral effectLicia Bordi, Alessandra D'Auria, Federica Frasca, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 9, 2007
Plasma antibodies against Chlamydia trachomatis, human papillomavirus, and human herpesvirus type 8 in relation to prostate cancer: a prospective studySiobhan Sutcliffe, Edward Giovannucci, Charlotte A Gaydos, et al.International Journal of Cancer|June 30, 2005
Antibodies to JC and BK viruses among persons with non-Hodgkin lymphomaEric A Engels, Dana E Rollison, Patricia Hartge, et al.Pageof 10